We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

200 hedge funds and large institutions have $2.61B invested in NPS PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 82 increasing their positions, 69 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 69

3% less call options, than puts

Call options by funds: $73.7M | Put options by funds: $76.2M

7% less funds holding

Funds holding: 215 → 200 (-15)

22% less capital invested

Capital invested by funds: $3.36B → $2.61B (-$750M)

30% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 44

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
200
Holders Change
-15
Holders Change %
-6.98%
% of All Funds
5.8%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
31
Increased
82
Reduced
69
Closed
44
Calls
$73.7M
Puts
$76.2M
Net Calls
-$2.52M
Net Calls Change
+$6.98M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$59.3M
2
BGIM
Brandywine Global Investment Management
Pennsylvania
+$33.8M
3
PAI
Palo Alto Investors
California
+$31.3M
4
PCM
Pentwater Capital Management
Florida
+$29.8M
5
Wells Fargo
Wells Fargo
California
+$22.8M

Top Sellers

Rank Fund Capital Flow
1
ORI
Oak Ridge Investments
Illinois
-$93.9M
2
TCM
TimesSquare Capital Management
New York
-$45.8M
3
TCIM
TIAA CREF Investment Management
New York
-$42.6M
4
Deutsche Bank
Deutsche Bank
Germany
-$20.7M
5
Norges Bank
Norges Bank
Norway
-$20.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
ORI
201
Oak Ridge Investments
Illinois
– -$93.9M -2,846,527 Closed
TCM
202
TimesSquare Capital Management
New York
– -$45.8M -1,386,950 Closed
O
203
OppenheimerFunds
New York
– -$17.2M -520,030 Closed
AC
204
Apex Capital
California
– -$15.7M -475,000 Closed
EPCM
205
Eton Park Capital Management
New York
– -$13.5M -408,141 Closed
TAL
206
TIG Advisors LLC
New York
– -$9.02M -272,927 Closed
D.E. Shaw & Co
207
D.E. Shaw & Co
New York
– -$7.58M -263,773 Closed
RIM
208
Rainier Investment Management
Washington
– -$6.44M -194,850 Closed
CIP
209
Chartwell Investment Partners
Pennsylvania
– -$5.53M -167,189 Closed
DKCM
210
Davidson Kempner Capital Management
New York
– -$5.38M -162,696 Closed
Stifel Financial
211
Stifel Financial
Missouri
– -$4.78M -144,633 Closed
FLAM
212
First Light Asset Management
Minnesota
– -$2.76M -83,563 Closed
PP
213
Paloma Partners
Connecticut
– -$2.48M -75,000 Closed
WIC
214
Water Island Capital
New York
– -$2.37M -71,746 Closed
SCM
215
Suffolk Capital Management
New York
– -$2.2M -66,500 Closed
FIG
216
Fortress Investment Group
New York
– -$1.78M -54,000 Closed
EI
217
EAM Investors
California
– -$1.65M -49,983 Closed
ACM
218
Atika Capital Management
New York
– -$1.55M -47,000 Closed
GTC
219
Ghost Tree Capital
New York
– -$1.32M -40,000 Closed
SGH
220
Sivik Global Healthcare
Connecticut
– -$1.32M -40,000 Closed
Zurich Cantonal Bank
221
Zurich Cantonal Bank
Switzerland
– -$1.16M -35,000 Closed
ARC
222
Absolute Return Capital
Massachusetts
– -$930K -28,142 Closed
MCM
223
Moore Capital Management
New York
– -$826K -25,000 Closed
GA
224
Geneva Advisors
Illinois
– -$740K -22,390 Closed
OAM
225
Oxford Asset Management
United Kingdom
– -$703K -21,186 Closed
6 7 8
9
10

NPSP Hedge Fund Activity: Q3 2014 in Review

200 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q3 2014, worth a combined $2.61B — down 22% from $3.36B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of NPSP and 31 opened new positions — a net loss of 13 holders — while 69 trimmed existing stakes and 82 added.

The largest buyer was OrbiMed, adding an estimated $59.3M. The largest seller was Oak Ridge Investments, exiting entirely with an estimated $93.9M sold.

  • 200 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q3 2014, down from 215 in Q2 2014.
  • Funds reported $2.61B of NPS PHARMACEUTICALS INC stock for Q3 2014, down 22% quarter-over-quarter.
  • 31 funds opened new NPS PHARMACEUTICALS INC positions in Q3 2014 and 44 closed out, a net change of -13 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q3 2014 was OrbiMed, an estimated $59.3M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q3 2014 was Oak Ridge Investments, an estimated $93.9M sold.

Based on aggregated 13F filings for Q3 2014.